Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2017 (748 publications)

no pagination
Papadopoulos KP, Gluck L, Martin LP, Olszanski AJ, Tolcher AW, Ngarmchamnanrith G, Rasmussen E, Amore B, Nagorsen D, Hill JS, Stephenson J. First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients With Advanced Solid Tumors. Clin Cancer Res. 2017 Oct;23(19):5703-10.
Pelosi G, Sonzogni A, Harari S, Albini A, Bresaola E, Marchiò C, Massa F, Righi L, Gatti G, Papanikolaou N, Vijayvergia N, Calabrese F, Papotti M. Classification of pulmonary neuroendocrine tumors: New insights. Translational lung cancer research. 2017 Oct;6(5):513-29.   PMCID: PMC5653522
Ralff MD, Lulla AR, Wagner J, El-Deiry WS. ONC201: A new treatment option being tested clinically for recurrent glioblastoma. Translational Cancer Research. 2017 Oct;6:S239-S243.
Ramamurthy C, Chertock Y, Hall MJ. Randomized Controlled Trials in Hereditary Cancer Syndromes. Surgical Oncology Clinics of North America. 2017 Oct;26(4):729-50.
Ramos JD, Casey MF, Bamias A, De Giorgi U, Bellmunt J, Harshman LC, Ladoire S, Wong YN, Alva AS, Rosenberg JE, Galsky MD, Yu EY, Retrospective International Study of Cancers of the Urothelium I. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy. Clin Appl Thromb Hemost. 2017 Oct;23(7):755-60.
Reck M, Paz-Ares L, Bidoli P, Cappuzzo F, Dakhil S, Moro-Sibilot D, Borghaei H, Johnson M, Jotte R, Pennell NA, Shepherd FA, Tsao A, Thomas M, Carter GC, Chan-Diehl F, Alexandris E, Lee P, Zimmermann A, Sashegyi A, Pérol M. Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer. Lung Cancer. 2017 Oct;112:181-7.
Shastri A, Janakiram M, Mantzaris I, Yu YT, Londono JS, Verma AK, Barta SK. Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma. Oncotarget. 2017 Oct;8(45):78410-8.   PMCID: PMC5667971
Sigurdson ER. Preface. Surg Oncol Clin N Am. 2017 Oct;26(4):xv-xvi.
Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, Downs TM, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Preston MA, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Gurski LA. Bladder Cancer, Version 5.2017. Journal of the National Comprehensive Cancer Network. 2017 Oct;15(10):1240-67.
Winkels RM, Sturgeon KM, Kallan MJ, Dean LT, Zhang Z, Evangelisti M, Brown JC, Sarwer DB, Troxel AB, Denlinger C, Laudermilk M, Fornash A, DeMichele A, Chodosh LA, Schmitz KH. The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema. Contemporary clinical trials. 2017 Oct;61:63-72.
Yoo SK, Ahmed AA, Ileto J, Zaorsky NG, Deville C, Holliday EB, Wilson LD, Jagsi R, Thomas CR. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015. Int J Radiat Oncol Biol Phys. 2017 Oct;99(2):280-5.
Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clin Genitourin Cancer. 2017 Sep 30;15(3):e337-e343.
Skalka AMA. Finding, Conducting, and Nurturing Science: A Virologist's Memoir. Annual review of virology. 2017 Sep 29;4(1):1-35.
Zhang BW, Deng N, Tan Z, Levy RM. Stratified UWHAM and Its Stochastic Approximation for Multicanonical Simulations Which Are Far from Equilibrium. J Chem Theory Comput. 2017 Sep 28;13(10):4660-74.
Rossiter SE, Fletcher MH, Wuest WM. Natural Products as Platforms To Overcome Antibiotic Resistance. Chemical reviews. 2017 Sep 27;117(19):12415-74.
Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 Sep 26;18(11):1483-92.
Li PD, Liu Z, Cheng TT, Luo WG, Yao J, Chen J, Zou ZW, Chen LL, Ma C, Dai XF. Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin. Oncotarget. 2017 Sep 22;8(37):62057-68.   PMCID: PMC5617486
Isoda T, Moore AJ, He Z, Chandra V, Aida M, Denholtz M, Piet van Hamburg J, Fisch KM, Chang AN, Fahl SP, Wiest DL, Murre C. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate. Cell. 2017 Sep 21;171(1):103-119e18.   PMCID: PMC5621651
Semenova G, Stepanova DS, Dubyk C, Handorf E, Deyev SM, Lazar AJ, Chernoff J. Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis. Oncogene. 2017 Sep 21;36(38):5421-31.   PMCID: PMC5608634
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Post-Operative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017 Sep 20;.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2017


Last updated on Friday, February 02, 2018